Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria

Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study

Hydralazine Use and Risk of Vasculitis

Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use. A Systematic Review and Meta-Analysis

Molecular mechanisms and clinical patterns of ICI-associated acute kidney failure: an integrated pharmacovigilance and pathway analysis

The Mark of Confusion: Untangling the Circuit Split in Trademark Infringement Jurisprudence

Incidence and trends of adverse drug reactions during seasonal malaria chemoprevention among children: evidence from Ghana's pharmacovigilance database, 2015-2023

A dataset of medication images with instance segmentation masks for preventing adverse drug events

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management

Charting and Sidestepping the Pitfalls of Disproportionality Analysis

Med Op-Ed: TAVR Safety Signal, Limits of Famed Biobank, & More

Identification of Drug Repurposing Opportunities of Immunomodulatory Drugs for Inflammatory Bowel Disease Through Inverse Pharmacovigilance Signal Detection in the FAERS Database

Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA

The boom in counterfeit obesity drugs

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)

Preventability of Antibiotic-Associated Adverse Drug Reactions Reported to a Regional Pharmacovigilance Center: A Cross-Sectional Descriptive Study

Adverse Childhood Experiences and Treatment-Resistant Depression

Meningitis Risk for Young Adults With Chikungunya Vaccine

INFORME RACIM. Actualización sobre medicamentos retirados por motivos de seguridad en otros países y su permanencia en Argentina

GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

IMPLEMENTATION OF ACTIVE PHARMACOVIGILANCE SYSTEMS IN HEALTH SERVICES AND PHARMACEUTICAL INDUSTRIES: A CRITICAL ANALYSIS OF ANVISA’S REQUIREMENTS

Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants

Profeco y Cofepris alertan por comercialización ilegal de productos con Tirzepatida

FDA - Novo Nordisk Inc. – Warning Letter

FDA Launches New Adverse Event Look-Up Tool

Drug-associated Torsades de Pointes and QT Prolongation in Infants: A Focused Real-World Disproportionality Analysis Pharmacovigilance Study.

A multi-state cross-sectional assessment of essential medicine availability in Sudan during armed conflict

Señales de notificación desproporcionada de eventos supuestamente atribuibles a las vacunas contra la covid-19 en niños y adolescentes: estudio de casos/no casos, Brasil, 2022

Comparing infectious risk of Trastuzumab-deruxtecan to Trastuzumab-emtansine in patients with breast cancer

Building pharmacovigilance-ready datasets from resource-limited settings: Study of antiretroviral-associated ADRs in Melanesian patients

Reclaiming Pharmacovigilance: Bridging the Evidence–Practice Gap in Psychopharmacology

Data-driven medical devices and the EU MDR: mapping gaps in standards for regulatory compliance

FDA’s Regulatory Reforms to Unlock Competition and Lower Drug Costs Breaking the Biosimilar Bottleneck

Comparative Safety of Six First-Line Antiepileptic Monotherapies in Pediatric Epilepsy Using the United States FDA Adverse Event Reporting System

Surge el Centro Nacional de Farmacovigilancia y Tecnovigilancia (CENAFyT)

Long-term safety evaluation of mirtazapine: A real-world pharmacovigilance study based on the FAERS database

Data mining and analysis of adverse drug events of propofol in the general population and the elderly based on the US Food and Drug Administration Adverse Event Reporting System

La AEMPS publica el Informe Anual sobre Farmacovigilancia Veterinaria

“Is This Normal?”: Understanding and Managing Adverse Reactions

Two deaths reported to drug watchdog over potential link to weight-loss jabs

OTC Medications Expose Toddlers to Potentially Risky Parabens

Reducing drug failures with AI, human liver organoids

Perspectiva de género en problemas asociados a medicamentos de alto riesgo atendidos en urgencias

Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events and potential herb-drug interactions of plants used for psoriasis: A systematic review

Is intramuscular adrenaline used promptly against drug-induced anaphylaxis? A perspective from recent analyses of fatal cases in Japan

Relationship Between Trimethoprim-Sulfamethoxazole-Induced Hepatotoxicity and Cytochrome Protein 450 2C9 Using Food and Drug Administration Adverse Event Reporting System Database

Counterfeit Medicines in Informal Retail: A Governance and Complexity Perspective from South African Spaza Shops

Precision Pharmacotherapy and the Artificial Intelligence Revolution in the Neonatal Intensive Care Unit: Developmental Pharmacology, Drug Safety, and Generative Redesign

ChatGPT as a Tool for Perioperative Safety: Evaluating Drug Interaction Detection in Anesthetic Regimens

PERFIL EPIDEMIOLÓGICO E CLÍNICO DAS NOTIFICAÇÕES RELACIONADAS AOS EVENTOS ADVERSOS À TOXINA BOTULÍNICA NO BRASIL: UMA ANÁLISE DE DADOS DO VIGIMED (2018–2025)

Disproportionality Analysis and Timing of Drug-Induced Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Adverse Event Report Database

Prevalence of potentially inappropriate medication prescribing, inappropriate medication use, prescription omission and drug interactions among older adults in Ethiopia: a systematic review and meta-analysis

Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service

AI-Driven ADE: Detection and Clinician-Readable Explanation of Adverse Drug Events in Open Clinical

Exploring Drug Safety Through Knowledge Graphs: Protein Kinase Inhibitors as a Case Study

Radiation medicine and sustainable networks for global health and safety: institutional progress and perspectives from KIRAMS

Antiepileptic Drug-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Series

The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database

A real-world pharmacovigilance study of bempedoic acid plus ezetimibe fixed-dose combination based on the FDA FAERS database

Precautionary recall of blood pressure medication after packaging error

Polypharmacy Guidance: appropriate prescribing, making medicines safe, effective and sustainable 2026 – 2029

Primera reunión de 2026 del Comité de Seguridad de Medicamentos Veterinarios y del Comité Técnico del Sistema Español de Farmacovigilancia de Medicamentos Veterinarios

PAHO calls for strengthened pharmacovigilance following reports of misuse of GLP-1 medicines indicated for treating obesity in adults

Quantification and reduction of the health sector’s environmental impact

Counterfeit weight loss products claiming to contain GLP-1

Alerta Epidemiológica: Uso indebido de medicamentos agonistas del receptor GLP-1 y sus consideraciones para la Región de las Américas

Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study

Systematic Pharmacovigilance and Genetic Validation of Medications Associated With Organizing Pneumonia: Integrating FAERS Data With Multiomics Analysis

Artificial intelligence revolution in toxicology: Clinical precision, global equity, and the 2030 roadmap

INTERGENERATIONAL TRANSMISSION OF SMUGGLING AS A PROFESSION

New Deprescribing Guidance Marks an ‘Important Moment’ in Psychiatry

Alteraciones del metabolismo lipídico inducidas por fármacos: un análisis exploratorio de farmacovigilancia del mundo real basado en el sistema de notificación de eventos adversos de la FDA de EE. UU. (FAERS)

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database

Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic

Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System

Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Automated dispensing cabinets and nurse-related medication errors in inpatient settings: A systematic review

MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs